Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Medtronic
McKesson
McKinsey
Merck

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for PU-H71


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug PU-H71?

PU-H71 is an investigational drug.

There have been 5 clinical trials for PU-H71. The most recent clinical trial was a Phase 1 trial, which was initiated on May 23rd 2017.

The most common disease conditions in clinical trials are Neoplasms, Thrombocythemia, Essential, and Primary Myelofibrosis. The leading clinical trial sponsors are Samus Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, and National Cancer Institute (NCI).

There are seventy US patents protecting this investigational drug and six hundred and seventy international patents.

Recent Clinical Trials for PU-H71
TitleSponsorPhase
Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking RuxolitinibSamus Therapeutics, Inc.Phase 1
Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of MyelofibrosisSamus Therapeutics, Inc.Phase 1
PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast CancerSamus Therapeutics, Inc.Phase 1

See all PU-H71 clinical trials

Clinical Trial Summary for PU-H71

Top disease conditions for PU-H71
Top clinical trial sponsors for PU-H71

See all PU-H71 clinical trials

US Patents for PU-H71

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
PU-H71 ⤷  Sign up for a Free Trial Precise delivery of therapeutic agents to cell mitochondria for anti-cancer therapy University of Georgia Research Foundation Inc. (Athens, GA) ⤷  Sign up for a Free Trial
PU-H71 ⤷  Sign up for a Free Trial Constructs targeting AFP peptide/MHC complexes and uses thereof EUREKA THERAPEUTICS, INC. (Emeryville, CA) ⤷  Sign up for a Free Trial
PU-H71 ⤷  Sign up for a Free Trial Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-beta Berg LLC (Nashville, TN) ⤷  Sign up for a Free Trial
PU-H71 ⤷  Sign up for a Free Trial Antibody/T-cell receptor chimeric constructs and uses thereof EUREKA THERAPEUTICS, INC. (Emeryville, CA) ⤷  Sign up for a Free Trial
PU-H71 ⤷  Sign up for a Free Trial Resistant mutant 90 kDa heat shock protein Taiho Pharmaceutical Co., Ltd. (Tokyo, JP) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for PU-H71

Drugname Country Document Number Estimated Expiration Related US Patent
PU-H71 World Intellectual Property Organization (WIPO) WO2006084030 2025-02-01 ⤷  Sign up for a Free Trial
PU-H71 European Patent Office EP3016715 2033-07-01 ⤷  Sign up for a Free Trial
PU-H71 Japan JP2016523926 2033-07-01 ⤷  Sign up for a Free Trial
PU-H71 World Intellectual Property Organization (WIPO) WO2015002996 2033-07-01 ⤷  Sign up for a Free Trial
PU-H71 Australia AU2016243026 2035-04-03 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Medtronic
McKesson
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.